Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå : ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, ¾Ï À¯Çüº°, Ä¡·á À¯Çüº°, ¹ÙÀÌ¿À¸¶Ä¿º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Precision Immuno-Oncology Market Size, Share, Growth Analysis, By Cancer Type (Lung Cancer, Breast Cancer), By Treatment Type (Checkpoint Inhibitors, Car T Cell Therapy), By Biomarker, By End Use, By Region - Industry Forecast 2025-2032
»óǰÄÚµå : 1623737
¸®¼­Ä¡»ç : SkyQuest Technology Consulting Pvt. Ltd.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 157 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,300 £Ü 7,668,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,200 £Ü 8,970,000
PDF & Excel (Multiple User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2-5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,100 £Ü 10,272,000
PDF & Excel (Enterprise License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 606¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â 672¾ï ´Þ·¯¿¡¼­ 2032³â¿¡´Â 1,526¾ï 5,000¸¸ ´Þ·¯·Î ¼ºÀåÇØ ¿¹Ãø ±â°£(2025-2032³â) CAGRÀº 10.8%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

Á¤¹Ð ¸é¿ªÁ¾¾çÇÐÀº ȯÀÚÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ, Á¾¾çƯ¼º, ¸é¿ª¹ÝÀÀÀ» °í·ÁÇÑ ¸ÂÃãÇü Ä¡·á¿¡ ÃÊÁ¡À» ¸ÂÃá ¾Ï Ä¡·áÀÇ ¼±±¸Àû Á¢±ÙÀ¸·Î¼­ ±Þ¼ÓÈ÷ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¸ÂÃãÇü Ä¡·á´Â Ä¡·áÈ¿°ú¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó ±âÁ¸ÀÇ Ä¡·á¹ý¿¡ ºñÇØ ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϰí Àå±âÀûÀÎ °üÇØ¿¡ ´ëÇÑ Èñ¸ÁÀ» °¡Á®¿É´Ï´Ù. ÀÓ»ó½ÃÇèÀº ƯÈ÷ Ä¡·á ÀúÇ×¼º ¾Ï ȯÀÚ¿¡¼­ À¯¸ÁÇÑ °á°ú¸¦ ³ªÅ¸³»¸ç ȯÀÚÀÇ ¹ÝÀÀÀÌ ¶Ñ·ÇÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ ºÐ¾ß¿¡¼­´Â Á¦¾à ȸ»ç°¡ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐÀÇ º¯È­ °¡´É¼ºÀ» ÀνÄÇÔ¿¡ µû¶ó ¸¹Àº ÅõÀÚ°¡ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ¾Ï Ä¡·áÀÇ ÁøÈ­¿¡ À־ Áß¿äÇÑ ÀÌÁ¤Ç¥°¡ µÇ¾î ½ÃÀå¿¡¼­ÀÇ À¯¸ÁÇÑ Àå·¡¼ºÀ» µ¸º¸À̰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

¼­¹®

Á¶»ç ¹æ¹ý

ÁÖ¿ä ¿ä¾à

½ÃÀå ¿ªÇаú Àü¸Á

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

¼¼°èÀÇ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå ±Ô¸ð : ¾Ï À¯Çüº°

¼¼°èÀÇ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå ±Ô¸ð : Ä¡·á À¯Çüº°

¼¼°èÀÇ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå ±Ô¸ð : ¹ÙÀÌ¿À¸¶Ä¿º°

¼¼°èÀÇ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå ±Ô¸ð : ÃÖÁ¾ ¿ëµµº°

¼¼°èÀÇ Á¤¹Ð ¸é¿ªÁ¾¾çÇÐ ½ÃÀå ±Ô¸ð : Áö¿ªº°

°æÀï Á¤º¸

ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ

°á·Ð°ú ±ÇÀå»çÇ×

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Precision Immuno-Oncology Market size was valued at USD 60.65 billion in 2023 and is poised to grow from USD 67.20 billion in 2024 to USD 152.65 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Precision immuno-oncology is swiftly gaining traction as a pioneering approach in cancer treatment, focusing on tailored therapies that consider patients' genetic profiles, tumor characteristics, and immune responses. This personalized strategy not only enhances treatment efficacy but also minimizes side effects compared to conventional therapies, offering hope for long-term remissions. Advanced diagnostics play a crucial role in identifying unique genetic mutations and proteins on cancer cells, enabling targeted interventions. Clinical trials have demonstrated encouraging results, particularly in patients with treatment-resistant cancers, showcasing remarkable patient responses. The sector is witnessing substantial investment as pharmaceutical companies recognize the transformative potential of precision immuno-oncology, marking a significant milestone in the evolution of cancer care and highlighting its promising future in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Immuno-Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Immuno-Oncology Market Segmental Analysis

Global Precision Immuno-Oncology Market is segmented by cancer type, treatment type, biomarker, end use and region. Based on cancer type, the market is segmented into lung cancer, breast cancer, prostate cancer, melanoma and others. Based on treatment type, the market is segmented into checkpoint inhibitors, Car T Cell Therapy, cancer vaccines and others. Based on biomarker, the market is segmented into PD-L1, BRCA, KRAS, EGFR and others. Based on end use, the market is segmented into hospital, clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Immuno-Oncology Market

The Global Precision Immuno-Oncology market is witnessing significant growth driven by the rising incidence of cancer worldwide. As cancer remains a pressing health issue, the need for advanced treatment options is becoming increasingly urgent. Traditional therapies like chemotherapy and radiation often have severe limitations and side effects, leading to a push for more innovative solutions. Precision immuno-oncology stands out by harnessing the body's immune system to combat cancer effectively. This tailored approach enables the development of targeted therapies based on individual genetic profiles, tumor characteristics, and immune responses, potentially enhancing treatment efficacy while minimizing adverse effects, thus propelling market demand.

Restraints in the Global Precision Immuno-Oncology Market

The Global Precision Immuno-Oncology market faces significant challenges primarily due to the high costs associated with these advanced therapies. Unlike traditional cancer treatments, precision immuno-oncology offers a personalized approach, which inherently involves complex and expensive methodologies. This heightened expense can restrict patient access, particularly for those in developing nations where healthcare resources are scarce. Factors such as exorbitant research and development expenditures, the requirement for specialized equipment, and the processes involved in biomarker testing further escalate costs. The unique treatment plans tailored for individual patients add another layer of expense, creating disparities in access to effective cancer care, especially for individuals from low- and middle-income regions, thereby exacerbating existing inequities in cancer treatment and outcomes.

Market Trends of the Global Precision Immuno-Oncology Market

The Global Precision Immuno-Oncology market is witnessing significant growth driven by the increasing adoption of combination therapies that integrate immunotherapy with traditional treatments like chemotherapy and radiation. This trend is rooted in the rising awareness of the enhanced treatment efficacy and the potential to combat drug resistance inherent in singular therapies. As research continues to yield promising results-especially in complex cancers such as lung cancer and melanoma-clinicians are increasingly leveraging these multi-faceted treatment approaches to improve patient outcomes. Furthermore, advancements in biomarker identification and personalized medicine are expected to further propel market expansion, catering to a more tailored cancer treatment landscape.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Precision Immuno-Oncology Market Size by Cancer Type & CAGR (2025-2032)

Global Precision Immuno-Oncology Market Size by Treatment Type & CAGR (2025-2032)

Global Precision Immuno-Oncology Market Size by Biomarker & CAGR (2025-2032)

Global Precision Immuno-Oncology Market Size by End Use & CAGR (2025-2032)

Global Precision Immuno-Oncology Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â